GLP-1 pills are coming, and they could revolutionize weight-loss …
Sep 17, 2024 · At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, with the most advanced now in the third and final stage of testing.
Next-generation drug from Eli Lilly boosts weight loss to 24% ... - CNN
Jun 26, 2023 · Eli Lilly’s Mounjaro, cleared for type 2 diabetes and awaiting FDA approval for weight loss, targets both GLP-1 and a hormone called GIP, and has produced weight loss of 21 to 23%.
Beyond Ozempic: New GLP-1 drugs promise weight loss and …
On Thursday, ahead of the diabetes conference, Denmark-based biotech firm Zealand Pharma released data that showed a high dose of its experimental weight loss drug petrelintide helped reduce body...
Considering GLP-1 medications? What they are and why lifestyle …
The good news is a class of medications called GLP-1 (glucagon-like peptide 1) agonists are emerging as true game changers, helping to control appetite and hunger, and allowing some people to shed pounds they’ve struggled to lose for years.
Many people using GLP-1s for weight loss stop treatment too soon ... - CNN
May 21, 2024 · An analysis of health insurance claims released Tuesday found that most people using GLP-1 medications – about 58% – were on their treatment plan for less than 12 weeks, falling short of a key...
The Race for the Next Ozempic | WIRED
Jul 24, 2024 · The revelation led the US Food and Drug Administration to approve the first GLP-1 drug for weight loss in 2014. Called liraglutide and sold under the brand name Saxenda, the weekly injectable...
The Ozempic-like obesity drugs create a dilemma when people …
May 27, 2024 · More and more people who started taking the new GLP-1 agonist drugs are now confronting the realities of their limitations; medications like Wegovy and Mounjaro tend to help with sustained weight...
After GLP-1, what’s next for weight loss? - Nature
Jun 6, 2023 · The GLP-1 agonist Wegovy has re-energized the hunt for obesity treatments. Alternatives — ranging from bitter taste compounds to lean muscle boosters and bacteria — are already in the clinic.
New GLP-1 weight loss drug Zepbound approved by FDA: What …
Nov 14, 2023 · Eli Lilly's new obesity medication Zepbound (tirzepatide) recently received FDA approval. Experts explain how the GLP-1 drug works and compares to similar drugs.
How Ozempic, other weight-loss drugs are "changing medicine"
Jan 21, 2024 · GLP-1 class medications reduce cardiovascular risk and treat diabetes. But they also allow people to lose an average of 10-20 percent of their body weight in the first year.